Clinical Genetics · Boston, MA
NPI
1558320762
Since 2006
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
55 Fruit St Yaw 8b, Pediatric Hematology Oncology
Boston, MA, 02114
Phone (617) 726-2737
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,498
108 services
Medicare patients, 2024
17
Average age 40
Drug cost, 2024
$1.7M
85 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Sweetser was code G2212 (prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or), 39 times for 11 patients. In total David A Sweetser billed 108 services in 10 codes, and Medicare paid $7,498.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 39 | 11 | $26.39 | $1,029 |
By year: 2022 $6,174 for 111 services; 2023 $6,304 for 100 services; 2024 $7,498 for 108 services.
Medicare prescription drug claims, 2024
In 2024, the drug David A Sweetser prescribed most often to Medicare patients was Levocarnitine, with 27 prescriptions and refills. In total David A Sweetser wrote 85 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocarnitine Generic | 27 | 43 | Under 11 | $4,341 |
| Ravicti Glycerol Phenylbutyrate | 23 | 23 | Under 11 | $1.6M |
| Leucovorin Calcium Generic | 13 | 13 | Under 11 | $5,167 |
Brand drugs: 23 claims; generic drugs: 62 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to David A Sweetser were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.